The ELEVATUM study explored faricimab's effectiveness in treating diabetic macular edema among underrepresented minorities, ...

Diabetic retinopathy, a common complication of diabetes, can damage the retina and lead to blindness. Early symptoms like ...

China: A recent study, published in BMC Endocrine Disorders uncovered a non-linear association between dietary iron intake ...

Lake Oswego, Oregon – As advancements in laser eye surgery continue to expand access to vision correction, individuals with ...

For patients with diabetes, exposure to glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with an increased ...

A new study brings into focus the relationship between diabetic GLP-1 users and the elevated risk of age-related eye disease.

Patients with diabetes who utilize GLP-1 RAs for 6 months or longer are twice as likely to develop neovascular age-related macular degeneration.

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.

While overall risk of macular degeneration remained low, a study suggests that GLP-1 drugs may have increased that risk in ...

Diabetes and thyroid disorders often go hand-in-hand, impacting how your body uses energy and controls blood sugar. In India, ...

New data from the CONFIDENCE trial demonstrates that combination therapy with finerenone and empagliflozin leads to ...

Dr. Lessieur-Contreras will continue her groundbreaking research on understanding the early stages of diabetic retinopathy ...